Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H26N2O2 |
Molecular Weight | 290.4005 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN1CCCC[C@H]1C(=O)NC2=C(C)C(O)=CC=C2C
InChI
InChIKey=IXOVDWXTIIYVOJ-AWEZNQCLSA-N
InChI=1S/C17H26N2O2/c1-4-10-19-11-6-5-7-14(19)17(21)18-16-12(2)8-9-15(20)13(16)3/h8-9,14,20H,4-7,10-11H2,1-3H3,(H,18,21)/t14-/m0/s1
Molecular Formula | C17H26N2O2 |
Molecular Weight | 290.4005 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:41:02 GMT 2023
by
admin
on
Sat Dec 16 09:41:02 GMT 2023
|
Record UNII |
L9A41F1FKO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
24892799
Created by
admin on Sat Dec 16 09:41:02 GMT 2023 , Edited by admin on Sat Dec 16 09:41:02 GMT 2023
|
PRIMARY | |||
|
L9A41F1FKO
Created by
admin on Sat Dec 16 09:41:02 GMT 2023 , Edited by admin on Sat Dec 16 09:41:02 GMT 2023
|
PRIMARY | |||
|
163589-30-8
Created by
admin on Sat Dec 16 09:41:02 GMT 2023 , Edited by admin on Sat Dec 16 09:41:02 GMT 2023
|
PRIMARY | |||
|
DTXSID70439025
Created by
admin on Sat Dec 16 09:41:02 GMT 2023 , Edited by admin on Sat Dec 16 09:41:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
Have a pharmacological activity in animal models less than that of ropivacaine
|